Authors:
GORETZKI L
BOGNACKI J
KOPPITZ M
RETTENBERGER P
MAGDOLEN V
CREUTZBURG S
HAMMELBURGER J
WEIDLE UH
WILHELM O
KESSLER H
GRAEFF H
SCHMITT M
Citation: L. Goretzki et al., QUANTITATIVE ASSESSMENT OF INTERACTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS RECEPTOR (CD87) BY USE OF A SOLID-PHASE UPA-LIGAND BINDING ASSAY, Fibrinolysis & proteolysis, 11(1), 1997, pp. 11-19
Authors:
ANDRONICOS NM
RANSON M
BOGNACKI J
BAKER MS
Citation: Nm. Andronicos et al., THE HUMAN ENO1 GENE-PRODUCT (RECOMBINANT HUMAN ALPHA-ENOLASE) DISPLAYS CHARACTERISTICS REQUIRED FOR A PLASMINOGEN BINDING-PROTEIN, Biochimica et biophysica acta. Protein structure and molecular enzymology, 1337(1), 1997, pp. 27-39
Citation: Aar. Higazi et al., INTERACTION OF SINGLE-CHAIN UROKINASE WITH ITS RECEPTOR INDUCES THE APPEARANCE AND DISAPPEARANCE OF BINDING EPITOPES WITHIN THE RESULTANT COMPLEX FOR OTHER CELL-SURFACE PROTEINS, Blood, 88(2), 1996, pp. 542-551
Citation: J. Bognacki et J. Hammelburger, FUNCTIONAL AND IMMUNOLOGICAL METHODS FOR THE MEASUREMENT OF HUMAN TISSUE FACTOR PATHWAY INHIBITOR, Blood coagulation & fibrinolysis, 6, 1995, pp. 65-72
Authors:
UPSON RH
COHEN RL
HIGAZI AA
MANUPPELLO J
BOGNACKI J
HENKIN J
MCCRAE KR
KOUNNAS M
STRICKLAND D
CINES DB
Citation: Rh. Upson et al., SOLUBLE UROKINASE RECEPTOR PROMOTES THE BINDING OF UROKINASE TO NOVELCELL-SURFACE DETERMINANTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1410-1410